v3.26.3
Consolidated Balance Sheets - USD ($)
shares in Millions, $ in Millions
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 4,085 $ 3,556
Accounts receivables, net of allowance for credit losses of $71 million and $81 million as of September 30, 2026 and December 31, 2025, respectively. 3,837 3,709
Inventories 3,173 3,179
Prepaid expenses 1,014 1,122
Other current assets 658 539
Assets held for sale 1,836 1,842
Total current assets 14,602 13,946
Deferred income taxes 2,057 2,191
Other non-current assets 269 405
Property, plant and equipment, net 3,747 4,080
Operating lease right-of-use assets, net 321 345
Identifiable intangible assets, net 3,303 3,781
Goodwill 15,742 16,000
Total assets 40,042 40,748
Current liabilities:    
Short-term debt 4,038 1,820
Sales reserves and allowances 3,955 4,143
Accounts payables 2,551 2,531
Employee-related obligations 588 739
Accrued expenses 2,962 2,687
Other current liabilities 1,036 1,182
Liabilities held for sale 296 354
Total current liabilities 15,425 13,456
Long-term liabilities:    
Deferred income taxes 263 296
Other taxes and long-term liabilities 3,422 3,808
Senior notes and loans 12,680 14,986
Operating lease liabilities 266 288
Total long-term liabilities 16,632 19,379
Commitments and contingencies, see note 10
Total liabilities $ 32,057 $ 32,834
Ordinary shares, authorized (in shares) 2,495 2,495
Teva shareholders’ equity:    
Ordinary shares of NIS 0.10 par value per share; September 30, 2026 and December 31, 2025: authorized 2,495 million shares; issued 1,272 million shares and 1,257 million shares, respectively. $ 59 $ 58
Additional paid-in capital 28,309 28,133
Accumulated deficit (13,736) (13,762)
Accumulated other comprehensive loss (2,556) (2,391)
Treasury shares as of September 30, 2026 and December 31, 2025 : 105 million ordinary shares and 107 million ordinary shares, respectively (4,097) (4,128)
Equity, Attributable to Parent 7,979 7,910
Non-controlling interests 5 4
Total equity 7,984 7,914
Total liabilities and equity $ 40,042 $ 40,748